Related Experiment Video
Updated: May 18, 2026

Rapid Isolation of Dorsal Root Ganglion Macrophages
Published on: September 7, 2019
P2X4 receptors of microglia in neuropathic pain
1Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi, Fukuoka 812-8582, Japan. inoue@phar.kyushu-u.ac.jp
Abstract:
We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12 receptors) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Especially P2X4 receptors (P2X4Rs) make a critical contribution to the pain processing. P2X4Rs of microglia might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial P2X4Rs may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project. Recently, we found that CCL21 regulates the expression of P2X4Rs in different manners, respectively. These new findings also provide novel targets for developing anti-neuropathic pain medicines.
Insights
Spinal microglia express purinoceptors, particularly P2X4Rs, which are key in neuropathic pain. Targeting these P2X4Rs offers a potential treatment for pain without affecting normal sensitivity.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Neuropathic pain arises after peripheral nerve injury, involving spinal microglia activation.
- Purinergic signaling, mediated by receptors like P2X4Rs, plays a critical role in pain processing.
- Microglial P2X4 receptors (P2X4Rs) are implicated in the development of neuropathic pain.
Purpose of the Study:
- To investigate the role of spinal microglia purinoceptors in neuropathic pain.
- To identify P2X4Rs as potential therapeutic targets for neuropathic pain treatment.
- To explore the regulatory mechanisms of P2X4R expression in the context of nerve injury.
Main Methods:
- Analysis of purinoceptor expression in spinal microglia following peripheral nerve injury.
- Investigation of factors activating microglia and their contribution to pain signaling.
- Examination of the specific role of P2X4Rs in pain processing and modulation.
Main Results:
- P2X4Rs expressed on spinal microglia are critical contributors to neuropathic pain.
- Upregulation of P2X4R expression or activity is predominantly observed in activated microglia.
- CCL21 was identified as a regulator of P2X4R expression, offering novel therapeutic insights.
Conclusions:
- Targeting microglial P2X4Rs presents a promising strategy for treating neuropathic pain.
- Interference with P2X4Rs may selectively alleviate pathological pain without affecting normal pain sensation.
- Novel therapeutic targets for anti-neuropathic pain medicines have been identified through understanding P2X4R regulation.
Related Concept Videos
Nociception
Opioid Receptors: Overview
Analgesia and Pain Management
Pain
Acute Inflammation III: Local and Systemic Effects